Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 15,869Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Verzenio

PharmaCompass

01

Brand Name : Verzenio

Abemaciclib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Verzenio

arrow
Indo Livestock Expo
Not Confirmed

Abemaciclib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 913

2019 Revenue in Millions : 580

Growth (%) : 57

blank

02

Brand Name : Verzenio

Abemaciclib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Verzenio

arrow
Indo Livestock Expo
Not Confirmed

Abemaciclib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 1,350

2020 Revenue in Millions : 913

Growth (%) : 48

blank

03

Brand Name : Verzenio

Abemaciclib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Verzenio

arrow
Indo Livestock Expo
Not Confirmed

Abemaciclib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 2,483

2021 Revenue in Millions : 1,350

Growth (%) : 84

blank

04

Brand Name : Verzenio

Abemaciclib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Verzenio

arrow
Indo Livestock Expo
Not Confirmed

Abemaciclib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 3,863

2022 Revenue in Millions : 2,484

Growth (%) : 56

blank

05

Brand Name : Verzenio

Abemaciclib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Verzenio

arrow
Indo Livestock Expo
Not Confirmed

Abemaciclib

Main Therapeutic Indication : Oncology

Currency : USD

2024 Revenue in Millions : 5,307

2023 Revenue in Millions : 3,863

Growth (%) : 37

blank

06

Brand Name : Verzenio

Abemaciclib

arrow
Indo Livestock Expo
Not Confirmed

Brand Name : Verzenio

arrow
Indo Livestock Expo
Not Confirmed

Abemaciclib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 580

2018 Revenue in Millions : 255

Growth (%) : 127

blank